Interestingly, this study also found that miRNA-375 in combination with cisplatin to treat the double oncogenes Akt/Ras-induced primary HCC mouse model could significantly delay the recurrence of tumor, indicating that the effect mechanism seems to be associated with the inhibition of the Akt signaling pathway by miR-375. This evidence concerns the gene AKT1 and neoplasm.